INTRODUCTION
============

Typical physical activity monitoring systems use a multiple axis accelerometer, converting acceleration data to an activity count or calorie expenditure ([@B1][@B2]), with the reliability and feasibility of these accelerometer-based physical activity monitoring systems having been established ([@B3]). However, these conventional physical activity monitors only measure the quantity of movement and do not provide information on physical fitness, which is specifically related to the ability or capacity for physical activity. Therefore, the purpose of exercise should be to increase both physical activity and fitness ([@B4]) and, hence, monitoring physical fitness is as important as physical activity monitoring.

Cardiorespiratory fitness (CRF), which is one component of physical fitness, is the ability to take in oxygen and to provide this oxygen to the exercising muscles. The importance of CRF in health has been emphasized in previous studies. Blair et al. ([@B5]) and Lee et al. ([@B6]) have reported that CRF is related to mortality due to all causes, including death due to a cardiovascular event. Moreover, in previously published research, we reported lower CRF to be associated with higher prevalence of renal hyperfiltration, an early marker of chronic kidney disease ([@B7]). CRF is influenced not only by non-modifiable factors, such as genetic factors, age, and gender, but also by modifiable factors, including regular aerobic exercise ([@B8][@B9]). Blair et al. ([@B5]) indicated that CRF can be enhanced through exercise, lowering the overall risk of mortality from all causes. However, CRF has not received its deserved attention in health care and research ([@B6]). The absence of practical and reliable methods to measure CRF is likely to be a contributing factor to this.

The maximal oxygen consumption (VO~2~max) is a representative index of CRF, with several methods available to measure or estimate VO~2~max. Metabolic gas analysis during maximal exercise is the gold standard for measuring VO~2~max ([@B10]). However, maximal exercise testing is not safe for high-risk groups due to the high intensity exercise required ([@B6]), as well as because of the high level of motivation required to complete the test ([@B11]). In addition, these tests require expensive equipment and expertise in aerobic exercise testing. Moreover, repeated maximal exercise test for monitoring of VO~2~max after modification of life styles is not practical.

To overcome the limitations of maximal exercise testing, submaximal tests ([@B11][@B12]) have been developed. These are based on the linear relationship between oxygen consumption, exercise intensity, and physical responses, such as heart rate (HR). However, like maximal exercise testing, submaximal exercise tests are not suitable for repeated testing and require specific equipment and expertise. Moreover, outcomes of these tests can easily be affected by the familiarity of the exercise ([@B11]). Recently, estimation methods of VO~2~max without the use of a specific exercise protocol in daily life have been developed, using accelerometers with ([@B13][@B14]) or without ([@B15][@B16]) continuous HR monitoring. The non-protocol VO~2~max estimation methods are based on the relationship between physical activity, HR (response of body to physical activity), and VO~2~max. Individuals with a higher level of VO~2~max are assumed to be more active ([@B15][@B16]) and to have greater potential for being active, with a lower HR, compared to individuals with a lower VO~2~max ([@B13][@B14]). Although the developed methods are simple and safe for high-risk groups, prolonged measurement with an attached sensor for up to 7 days makes these methods impractical in daily life ([@B14]).

In this study, we developed an unobtrusive VO~2~max estimation model, using maximal activity energy expenditure (aEEmax) as a new feature, to indicate personal physical activity. aEEmax was calculated based on activity energy expenditure (aEE) and HR measured in daily life. Our model decreased the estimation time to reduce discomfort to individuals.

MATERIALS AND METHODS
=====================

Participants
------------

Twenty-four healthy young Asian male volunteers participated in this study. All participants had sedentary occupations. All participants signed written informed consent. Participants also completed health evaluations, including medical history related to cardiovascular disease.

Measurement of VO~2~max
-----------------------

VO~2~max was measured using a respiration gas analyzer (Vmax Encore System; CareFusion,

San Diego, CA, USA) and an aerobic exercise test system (CASE v6.61; GE Healthcare, Little Chalfont, UK). The modified Bruce protocol was used to determine the VO~2~max reference value. Twelve-lead electrocardiogram (ECG), blood oxygen saturation (SpO~2~), and blood pressure were also measured.

First, baseline physiologic measures for all devices used were measured in a standing position after a 5-minute rest period. The modified Bruce protocol was subsequently performed, with the treadmill\'s velocity and slope increased at 3-minute intervals. The following criteria were used to define VO~2~max attainment: a respiratory exchange ratio reaching \> 1.08; cessation of increase in VO~2~ with increasing work load; or self-reported volitional fatigue ([@B17]). The value of VO~2~max was expressed in mL/kg/min.

Experimental methods
--------------------

Participants wore a Shimmer ECG sensor ([@B18]), for measurement of 2-lead ECG and tri-axial acceleration (Shimmer platform with ECG sensor module; Shimmer, Dublin, Ireland), for four consecutive days. The sensor was attached to the chest with an elastic chest belt. Participants removed the sensor during sleep or during showering, after which they re-attached the sensor after completing those activities using new ECG electrodes.

An ECG was obtained on the left side of the chest near the left nipple, using a hydrogel Ag/AgCl electrode (2223; 3M, Maplewood, MN, USA) with a 10-cm-sized, square-shaped placement. No adverse skin reactions, such as a rash, were identified. An electrode was not placed at conventional ECG lead positions as the sensor needed to be comfortably placed to avoid disrupting activities of daily living. The acceleration signal was also captured on the chest, with the sensitivity of the accelerometer set to 1.5 g. Ideally, accelerometers should be placed close to the center of body mass, but we placed the sensor on the chest to improve comfort during measurement ([@B19]). The X, Y, and Z axes corresponded to the longitudinal axis, the mediolateral axis and the posterior-anterior axis, respectively.

Data obtained from all signals were stored on a micro-SD card at a sampling frequency of 51.2-Hz, which is appropriate for the measurement of physical activity ([@B1]), but relatively lower than the standard ECG frequency ([@B20]). The sampling frequency was selected to reduce battery consumption without losing signal quality necessary to obtain the R-R intervals ([@B18]). The stored data were extracted two times, at 48-hour and 96-hour after initiating measurement.

Signal processing
-----------------

Whole data sets were reviewed and, if the ECG was inaccurate due to electrode contact problem or sensor detachment, the ECG and the matching accelerometer data were also removed. The tri-axial acceleration was band-pass filtered (0.25 to 7 Hz, 2nd order Butterworth). Filtered acceleration was rectified and integrated over 1-minute sequences to obtain the acceleration count per minute (ACM). A non-linear model for aEE estimation ([@B2]) was defined using body mass, gender, and ACM within the following Equations 1 to 7:

$$aEE  = a_{N} \times {{ACM}_{horizontal}}^{P1} +  b_{N} \times {{ACM}_{vertical}}^{P2}$$

$$p1  =  \frac{2.66  \times mass\left( {kg} \right) + 146.72}{1,000} $$

$$p2  =  \frac{- 3.85  \times mass\left( {kg} \right) + 968.28}{1,000}$$

$$a_{N}  =  \frac{12.81  \times mass\left( {kg} \right) + 843.22}{1,000}$$

$$b_{N}  =  \frac{38.90  \times mass\left( {kg} \right) - 682.44 \times sex + 692.50}{1,000} $$

, where sex = 1 in males and 2 in females

$${ACM}_{horizontal}  =  \sqrt{\left( {\int\left. \left| accelerometer \right._{y} \right|} \right)^{2} +  \left( {\int\left. \left| accelerometer \right._{z} \right|} \right)^{2}}$$

$${ACM}_{vertical}  =  {\int\left. \left| accelerometer \right._{x} \right|}$$

The ECG data were band-pass filtered (5 to 20Hz, 4th order Butterworth). The R-R interval was automatically detected from the ECG signal using the R-peak detection algorithm described by Pan and Tomkins ([@B21]). The R-R intervals were averaged for 1 minute and converted to an HR (beat per minute). Since previous research showed that the recovery HR after physical activity was heterogeneous ([@B22]) and not well correlated to VO~2~max ([@B23]), we used only increasing HR periods in our analysis.

[Fig. 1A](#F1){ref-type="fig"} shows the aEE (upper graph) and HR (lower graph) for a representative participant over time. The gray area under the HR curve indicates periods of increasing HR. As aEE increased, the associated HR increased. The scatter plot of HR and aEE, averaged over 1-minute intervals during periods of increasing HR are shown in [Fig. 1B](#F1){ref-type="fig"}. A simple linear regression equation was developed to estimate aEEmax, using HR and aEE as inputs, with the maximal HR calculated as 220 − age.

![Signal processing procedure. (**A**) aEE (in units of J/min), and HR (in units of beats per minute) for one participant. HR data is shown as a thick line and the increasing HR period (at least 4 minutes) is shown in the shadowed region under the smoothed HR curve. (**B**) Scatter plot of the aEE and HR of the same participant. A simple linear regression was performed to obtain aEEmax at a maximal HR (220 − age).\
aEE = activity energy expenditure, HR = heart rate, aEEmax = maximal activity energy expenditure.](jkms-32-1947-g001){#F1}

Following aEEmax calculation, participants were divided into two subgroups according to aEEmax. The aEEmax values were sorted in ascending order and every third participant was selected to form the test group (n = 8), with other participants forming the training group (n = 16). The aEEmax and anthropometric values were used to develop a multiple linear regression model to estimate the VO~2~max in the training group.

Statistical analysis
--------------------

Pearson\'s correlation coefficient was calculated to evaluate the agreement between the aEEmax and the measured VO~2~max, as well as between the estimated VO~2~max and the measured VO~2~max in both groups. A two-sided *P* \< 0.05 was regarded as significant. Regression equations were evaluated by coefficients of determination (adjusted R^2^), absolute standard error of the estimate (SEE), and relative SEE (%SEE). A Bland-Altman plot was plotted to determine the differences between measured and estimated VO~2~max. All signal processing, cross validation, and statistical analyses were performed using MATLAB (MATLAB2014a; Mathworks, Natick, MA, USA).

Ethics statement
----------------

The present study protocol was reviewed and approved by the Institutional Review Board of the National Medical Center (IRB. No. M-12111001-001). Informed consent was submitted by all subjects when they were enrolled. Participants also completed health evaluations, including medical history related to cardiovascular disease.

RESULTS
=======

Characteristics of the training and test groups are summarized in [Table 1](#T1){ref-type="table"}. No between-group differences were evaluated using the Mann-Whitney U test.

###### Characteristics of participants

![](jkms-32-1947-i001)

  Parameters                                          Training (n = 16)   Test (n = 8)   *P*
  --------------------------------------------------- ------------------- -------------- -------
  Age, yr                                             27.5 ± 6.6          25.1 ± 3.7     0.413
  Height, cm                                          172.6 ± 6.8         174.8 ± 6.2    0.724
  Weight, kg                                          70.1 ± 11.2         75.0 ± 9.6     0.269
  The duration of Bruce protocol exercise, sec        842 ± 89            796 ± 107      0.272
  Measured VO~2~max, mL/kg/min                        48.5 ± 5.3          46.8 ± 4.5     0.284
  The duration of the measurement using sensor, min   2,935 ± 767         3,319 ± 426    0.178

All values are mean ± standard deviation. *P* values were calculated using the Mann-Whitney U test.

VO~2~max = maximal oxygen consumption.

The change in the correlation coefficient between aEEmax and measured VO~2~max with respect to time is shown in [Fig. 2](#F2){ref-type="fig"}. A significant correlation between aEEmax and the measured VO~2~max (R = 0.81, *P* \< 0.001) with only 15-hour of recording during daily life. As the correlation coefficient showed little increase with longer duration of measurement, we only used 15-hour of ECG and acceleration data to estimate VO~2~max.

![Change of correlation coefficient between aEEmax and measured VO~2~max. The correlation coefficient was 0.81 at 900 minutes of HR and aEE data analysis to calculate aEEmax. The correlation coefficient fluctuated but did not drastically increase when longer periods were used.\
aEEmax = maximal activity energy expenditure, VO~2~max = maximal oxygen consumption, aEE = activity energy expenditure, HR = heart rate.](jkms-32-1947-g002){#F2}

The aEEmax and body mass index (BMI) were used to develop a multiple linear regression model to estimate the VO~2~max using the training data, with the regression formula, expressed as:

VO~2~max (mL/kg/min) = 0.192 × aEEmax (J/min) − 0.708 × BMI (kg·m^−2^) + 46.157

The estimated VO~2~max strongly correlated with the measured VO~2~max in both groups ([Table 2](#T2){ref-type="table"}).

###### Performance of multiple linear regression in both groups

![](jkms-32-1947-i002)

  Statistics       Training group (n = 16)   Test group (n = 8)
  ---------------- ------------------------- --------------------
  R                0.81 (*P* \< 0.001)       0.87 (*P* \< 0.01)
  Adjusted R^2^    0.63                      0.74
  SEE, mL/kg/min   4.40                      5.74
  %SEE             9.53                      11.85

R = correlation coefficient, Adjusted R^2^ = coefficient of determination, SEE = standard error of the estimate, %SEE = percentage of SEE relative to measured VO~2~max value, VO~2~max = maximal oxygen consumption.

The correlation between the estimated and measured VO~2~max, calculated for all participants, is shown in [Fig. 3A](#F3){ref-type="fig"}, with the Bland-Altman plot shown in [Fig. 3B](#F3){ref-type="fig"}, with the x-axis showing the average of estimated and measured VO~2~max, with the difference between estimated and measured VO~2~max (measured VO~2~max subtracted from estimated VO~2~max) plotted along the y-axis. The solid line shows the mean value and the dashed line the 1.96 standard deviation (SD) (95% limits of agreement). Values for participants were randomly dispersed within the 1.96 SD range, except for one participant. The mean difference (95% limits of agreement) between the measured and estimated VO~2~max was 1.26 mL/kg/min (−9.74, 7.22).

![The correlation between the estimated and measured VO~2~max. (**A**) Correlation between the estimated and measured VO~2~max value of all participants. The thin line is the identity line of the measured and estimated VO~2~max. (**B**) Bland-Altman plot (estimated-measured VO~2~max, n = 24). The solid line represents the mean value, and the dotted line represents the 1.96 SD (95% limit of agreement). With the exception of one participant, the data was randomly distributed among the 1.96 SD range.\
VO~2~max = maximal oxygen consumption, SD = standard deviation](jkms-32-1947-g003){#F3}

DISCUSSION
==========

In this study, we describe a VO~2~max estimation model based on the relationship between physical activity (aEE) and corresponding physiological response (HR), using combined ECG and tri-axial accelerometer data in healthy young men. As a strong correlation between the level of physical activity and CRF has been previously found ([@B14][@B16]), and we have added aEEmax as a new feature to quantify personal physical activity. As the VO~2~max measurement during maximal or submaximal exercise is based on an increase HR in response to physical exercise ([@B24]), and knowing that the heterogeneous recovery of HR from physical activity ([@B22]) does not strongly correlate with VO~2~max ([@B23]), we used the data corresponding to increased HR in our simple linear regression model to estimate aEEmax.

The estimated VO~2~max strongly correlated with the measured VO~2~max in both the training and test groups. The outlier identified on the Bland-Altman plot had the lowest measured VO~2~max (24.1 mL/kg/min) among all participants. The measured VO~2~max for this participant was extremely low compared to the average VO~2~max range (very poor, \< 33.0 mL/kg/min) of healthy young male, indicative of a possible error during VO~2~max measurement or a lower accuracy of the model for participants in the lower range of CRF.

Other CRF estimation methods, using indices of physical activity and physical response, have been reported ([@B13][@B14][@B25][@B26]). However, Weyand et al. ([@B25]) and Tönis et al. ([@B26]) used an exercise protocol to estimate VO~2~max. Plasqui and Westerterp ([@B13]) reported a VO~2~max estimation method without an exercise protocol using anthropometric values, HR and acceleration data collected over 7 days. The average HR divided by ACM negatively correlated with VO~2~max, and a multiple linear regression model was developed. After that study, a cross-validation study was conducted to establish a robust regression model (R = 0.86--0.90, R^2^ = 0.71--0.74, SEE = 341--437 mL/min) ([@B14]). Despite the efficacy of this model, the necessity to measure parameters for 7 days would make this method impractical. The separate attachment of an HR sensor and accelerometer could also make the individuals uncomfortable, thus causing behavioral changes. The unified sensor system used in our study appears to be less obtrusive than that of previous studies. Sartor et al. ([@B24]) indicated that future non-protocol VO~2~max estimation should use unobtrusive devices, with the assessment performed using a single day of activity, or even on a single physical activity.

We have improved upon previously available non-protocol based VO~2~max estimation methods in two ways. First, our method requires only 15-hour of signal measurement, which is the shortest time for VO~2~max estimation reported to date ([@B14]) and allows the possibility of estimating the VO~2~max using data gathered from activity in one and half days. Many patch-type devices have been developed to measure HR and acceleration, but these devices have not been successful in regular use due to inconvenience in operation. Therefore, by reducing the time taken for VO~2~max estimation, the proposed method improves upon the current standard. Second, the performance of the estimation regression model using aEEmax as a new feature was comparable to the results of previous studies, despite the reduced signal measurement time.

The limitations of our study need to be acknowledged. First, our participant group was relatively homogenous (healthy young men) and the sample size was not large enough to determine a representative pattern. Therefore, an additional study with a larger, more varied sample group is needed with a revised regression model including additional parameters, such as age and gender. Since age and gender are considered as parameters for calculating aEEmax from maximum HR and energy expenditure, aEEmax is expected to be an effective parameter for VO~2~max estimation even in a broad age range and gender. Second, changes in participants\' VO~2~max over the long-term should be monitored in a longitudinal study to verify the accuracy of our estimation algorithm. Third, chest-attached sensors, such as the one used in the present study, may not be sufficiently comfortable for use in daily life. Considering the widespread availability of fitness watches and trackers, which are more comfortable to use in daily life, and because these devices provide information regarding both HR and aEE, a follow-up study should be conducted using these devices to verify the accuracy of the proposed algorithm.

In summary, we have used a new feature, aEEmax, to estimate VO~2~max during daily activities. The new feature captures the relationship between physical activity and anthropometric values, without requiring a large data set, and successfully estimated VO~2~max in a small sample of healthy young men. The length of data required for VO~2~max estimation was only one and half days and the data were measured from a single device. The comparison of measured and estimated VO~2~max values revealed robust agreement and the correlation coefficient for the VO~2~max estimation algorithm was shown to be comparable to the values in previous studies.
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